How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

More Signal, Less Noise: AIM-MASH AI Assist as a solution to the scoring variability problem in MASH clinical trials

calendar_today November 5, 2026 person Admin domain path-ai

The landscape of metabolic dysfunction-associated steatohepatitis (MASH) drug development reached a potentially pivotal turning point in 2025. This was the year that PathAI’s AIM-MASH AI Assist* digital pathology tool achieved landmark regulatory recognition, securing both EMA qualification and FDA Drug Development Tool (DDT) qualification [1,2]. These regulatory milestones have brought the MASH field closer to a new era where integration of AI-powered scoring tools into clinical trials provide the standardized, reproducible scoring necessary for accurate trial enrollment and endpoint assessme

open_in_new Read original post